Squarepoint Ops LLC Pds Biotechnology Corp Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.55 - $4.02 $104,496 - $164,735	40,979 New	40,979 $120,000
Q4 2023 Feb 14, 2024	SELL	$3.95 - $6.58 $100,748 - $167,829	-25,506 Reduced 66.22%	13,011 $64,000
Q2 2023 Aug 14, 2023	SELL	$5.03 - $9.9 $321,940 - $633,639	-64,004 Reduced 62.43%	38,517 $193,000
Q1 2023 May 15, 2023	BUY	$5.68 - $11.99 $582,319 - $1.23 Million	102,521 New	102,521 $630,000

4.32M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $47M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.